argenx is a global biotechnology company headquartered in the Netherlands, specializing in the development of innovative therapies for severe autoimmune diseases and cancers. Founded in 2008, the company leverages its proprietary antibody discovery platform, derived from the immune system of llamas, to create unique therapeutic candidates. With a mission to empower patients through transformative medicines, argenx has established itself as a leader in immunology, focusing on conditions with high unmet medical needs.
argenx has grown rapidly, employing over 500 professionals across multiple international offices, including in Belgium, the United States, and Japan. Its flagship product, efgartigimod, has gained regulatory approvals for the treatment of generalized myasthenia gravis, marking a significant milestone in its journey. The company continues to expand its pipeline and partnerships, reinforcing its strong market position and reputation for scientific excellence. Recent developments include ongoing clinical trials for additional indications and strategic collaborations with leading pharmaceutical firms.
No open positions at argenx right now. Check back later!
Browse All Jobs →